Russell Investments Group, Ltd.

Position in EWTX — Edgewise Therapeutics, Inc.

CIK 1692234 Seattle, WA

Position in EWTX

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$3,158,288

+$2,951,208 QoQ

Shares Held

77,733

+1082.4% QoQ

Ownership

0.072%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#82

of 223 holders

Holding Since

Jun 2024

8 quarters on record

Voting authority Sole 91% Shared 0% None 9%

Healthcare · as of Jun 30, 2026

Russell Investments Group, Ltd. holds $1,494,413,888 across 308 Biotechnology names. EWTX ranks #68 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	336,990	$167,393,033
2	REGN	Regeneron Pharmaceuticals, Inc.	230,151	$143,508,345
3	RPRX	Royalty Pharma plc	1,694,250	$94,996,587
4	INCY	Incyte Corp	425,616	$48,247,822
5	ALNY	Alnylam Pharmaceuticals, Inc.	158,228	$47,631,369
6	BMRN	Biomarin Pharmaceutical Inc	783,148	$44,811,725
7	LGND	Ligand Pharmaceuticals Inc	120,304	$38,026,888
8	PTCT	Ptc Therapeutics, Inc.	418,025	$34,098,295

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,158,288	77,733	+1082.4%	Shares	Defined	2026-08-06
2026-03-31	$207,080	6,574	+1.2%	Shares	Defined	2026-05-08
2025-12-31	$161,147	6,494	-9.7%	Shares	Defined	2026-02-17
2025-09-30	$116,621	7,190	+29858.3%	Shares	Defined	2025-11-13
2025-06-30	$314	24	+26.3%	Shares	Defined	2025-08-13
2025-03-31	$418	19	-99.9%	Shares	Defined	2025-05-13
2024-12-31	$883,207	33,079	+977.5%	Shares	Defined	2025-02-13
2024-06-30	$55,290	3,070	—	Shares	Defined	2024-08-08
No filing history on record for this holder in this stock.